Multi Modal Analgesia

Size: px
Start display at page:

Download "Multi Modal Analgesia"

Transcription

1 Analgesic Drugs and Pharmacology Richard Craig R.N. B.N. M. Sci. Med (Pain Mgmt) Nurse Consultant Acute Pain Management Service Christchurch Hospital Multi Modal Analgesia Patients benefit from multi modal analgesia following surgery. Combinations of analgesic drugs are used to improve pain relief, reduce the dose of each analgesic drug and reduce intensity of side effects. Types of pain Nociceptor pain - Somatic Structures involved Skin,muscle,bones and tissues. Quality of pain- Easy to localize,stabbing, boring. movement dependant Nociceptor pain. VISCERAL Structures involved-parenchymatous organs,hollow viscera,peritoneum. Quality of pain: Difficult to localize,dull, oppressive,colicky. Neuropathic pain. Structures involved: Nociceptic system(peripheral nerves,spinal cord cerebrum) Quality of pain: Shooting, lancing, electric shock like, burning. Neuropathic pain Structures involved: Nociceptic system(peripheral nerves,spinal cord, cerebrum) Quality of pain: Shooting,lacinating,electric shock-like,burning 1

2 Classes of pain medications Paracetamol Non Steriodal Anti Inflammatories(NSAIDs) Codeine Tramadol Opioids Neuropathic pain options (TCA,Antiepileptics,NMDA receptor antagonists.) Topicals PARACETAMOL Mild to moderate pain Onset 10-30min, peak 1 hr Duration of action 4-6hrs Inexpensive, effective drug High bio availability,well absorbed with low side effect profile. Analgesic, antipyretic, weakly anti inflammatory actions. Adjunct to opioids in severe pain, (opioid sparing). Significant central action??cox 3 inhibitor (animal studies) 4gm/24hr P.O. Adult dose (Regular not PRN). Overdose / hepatic necrosis (alcohol/malnourishment may also be predisposing factors for hepatotoxicity). Dosing Adults:1 gm oral/rectal 4-6 hrly or 1gm IV (Perfalgen) Schoolchildren: 5oomg oral/rectal or 500mg IV Toddlers250mg rectal Infants 125mg rectal (General dose formula for single dose:20mg/kg body weight) Adverse effects In therapeutic doses well tolerated, minimal side effects. Death from overdose rare but does happen. Hepatotoxicity with overdose caused by metabolite N- acetyl-p-benzoquinone imine(napqi). NAPQI normally inactivated by combination with glutathione then excreted via kidneys. Excessive dosing paracetamol may exhaust livers glutathione stores. Antidote Parvalax. NSAIDS (Mechanism of action) Exhibit a spectrum of analgesic anti-inflammatory inflammatory antiplatlet and antipyretic actions. Inhibit the enzyme cyclo-oxygenase oxygenase which metabolizes arachidonic acid to a large number of eicosanoids, including prostaglandins,prostacycline and thromboxane. This mechanism of action explains the wide range of adverse effects of NSAIDS as eicosanoids have protective functions in the intestine mucosa,kidney and are linked to platelet function Anti-inflammatory inflammatory effect is related to reduction of prostaglandins which act as mediators of inflammation. Analgesic effect is result of decreased prostaglandin synthesis in the periphery leading to decreased sensitization of nociceptors. Also cyclo-oxygenase oxygenase inhibition in the CNS reduces prostaglandin formation in spinal cord and brain and thereby central sensitization. 2

3 Non Steroidal Anti Inflammatories (NSAIDS) Mild to moderate pain (unsuitable as the sole agent following major surgery but effective after minor surgery eg day stay/ gynae /dental. Relatively contraindicated post tonsillectomy) Anti inflammatory, anti pyretic,, analgesic. Reduce inflammation by blockade of prostaglandin synthesis. Enhance quality of opioid analgesia, opioid sparing, decrease opioid side effects. Especially good in dynamic movement pain.?? Role in malignancy prevention( eg bowel cancer.) RISKS/ DRAWBACKS Association with G. I. Ulceration and bleeding (cox 1) May cause renal dysfunction (extreme caution with elderly) Asthma in susceptible patients. Ceiling dose. Large and individual variation in minimal effective dose, toxic dose and ceiling dose. Cox 2s all under a cloud ( no platelet inhibition, increased risk of stroke M.I. with chronic use). May cause headache, constipation,cognitive impairment in elderly. Expensive. NSAIDS: Being Sensible Specifically look for contraindications, eg renal status, asthma, hx stomach ulcers Restrict duration of NSAID treatment to 2 to 4 days post op. (STOP DATE) If recommended doses fail to achieve pain relief increasing dose is unlikely to help (ceiling effect) Increasing doses increases risks of adverse effects,(recommended doses are already maximal) If one NSAID fails to achieve pain relief swapping to another is unlikely to help.(unlike opioid rotation). Patients at high risk Aged under 65 yrs and 2 risk factors. Aged over 65 yrs and one risk factor Risk Factors. Hx of peptic ulcer Hx of GI bleeding Concomitant use of meds eg anti coags, steriods. Significant co-morbidities eg CVD, cirrhosis Prolonged and high dose NSAID use. TRAMADOL Analgesic with minimal sedation, G.I. disturbance, resp. depression or abuse potential.(caution still indicated in pts with Hx drug abuse.) Weak Mu opioid agonist.(o-desmethyl Tramadol metabolite) Also has spinal and CNS effects via noradrenergic and serotoninergic pathways. Therefore both opioid and non opioid analgesic. Safer than other opioids in higher doses.(although still possible to cause sedation, resp. depression) Less constipating than other opioids. Tramadol Dosing Can be up to 600mg daily but usually 400mg maintenance dose (50-100mg 4-6hrly) 50mg tramadol approx equal to 60mg codeine for pain relief. Onset 1 hour after oral dose. Peak 2-4 hrs after oral dose. Duration of analgesia 9 hrs (approx) 3

4 DISADVANTAGES High affinity with nausea.( Start low and go slow may avoid this eg 50mg t.d.s.-100mg qid.) Parental tramadol produces less analgesia than equivalent morphine in severe post op pain. Contraindicated for pts taking SSRIs. Expensive. Elderly Patients Over 75 yrs recommended daily max is 300mg/day 50 mg doses may be preferable Some centres do not favour Tramadol in the elderly. Adverse Effects Common- nausea, vomiting, tremor,headache,rash,sweating. More serious reactions- confusion,hallucinations,convulsions,serotonin syndrome,hypertension,hepatic reactions, warfarin interactions. Serotonin Syndrome Tramadol may cause serotonin syndrome. Particularly at high doses or in conjunction with serotonin enhancing agents including anyidepressants,ondansetron,l dopa, lithium, and some illegal drugs such as amphetamines,cocaine,lsd,ecstacy. Diagnosis of Serotonin Syndrome Requires 3 of the following. changes in mental state. agitation. hyperflexia. Sweating. Tremor. diarrohoea. Fever. incoordination. Seizures Tramadol lowers the seizure threshold. Risk increases with excessive dosing. Caution in patients with hx of epilepsy,combination of other drugs which lower the seizure threshold (SSRI,opioids,antihistamines). Other seizure risks eg head injury, alcohol withdrawl,cns infections. 4

5 OPIOIDS TERMINOLOGY: OPIOIDS are drugs which bind to opioid receptors, this includes agonists such as morphine, pethidine and fentanyl as well as antagonists such as naloxone. OPIATES are drugs derived from opium, mostly morphine, codeine and their families. However it is commonly, but incorrectly, used to include other opioid agonists such as pethidine and methadone. NARCOTICS Term was originally used for drugs that produced sleep like state (narcosis), then for drugs (usually from opium) that both produced pain relief and sleep like state, it is no longer a medically useful term because it has been hi jacked into legal circles and is now often used to include many other drugs used illegally such as cannabanoids, amphetamines, etc that have nothing to do with opium. OPIOIDS Cornerstone of post op pain management for moderate to severe nociceptive pain. Effective and inexpensive. Produce sense of wellbeing and promote sleep. Act at supraspinal level (brain stem), spinal cord level(greatest density of opioid receptors around c fibre terminals in lamina 1 and in substansia gelatinosa, (70%Mu, 24% delta, 6% kappa) Peripherally CODEINE Analgesic for mild to moderate pain. Limited use in the management of severe pain. Undergoes less first pass metabolism than oral morphine.(60% effective orally as parentally) Once absorbed 10% of codeine is metabolised by liver to morphine. (CYP-2D6) 10% of adult population lack this ability therefore codeine will be ineffective for them. Probably the most constipating opioid. Abuse potential. Oxycodone OxyNorm=Immediate release tablets. Full dose absorbed in first mins with peak effect in mins. Usually dosed every 4-6 hrs. OxyContin=Controlled release capsule. Initial burst release of 40% of dose in first hour. Remaining 60% of dose releases slowly giving it a 12 hour duration of action. Oxycodone What is the difference between Oxycodone, oxynorm and oxycontin? 5

6 OPIOID RECEPTORS Opioid drugs act as agonists at opioid receptors located in brain spinal cord, urinary and G.I.tracts, lung and peripheral nerve endings. Three principal types of opioid receptor Mu, Kappa,Delta.(op3, op2, op1 new classification) endogenous agonists are B-endorphins, encaphalins and dynorphins respectively. Receptor Actions Mu- analgesia, resp depression,euphoria, bradycardia,pruritis, miosis, n+v, physical dependence,inhibition gut. Delta- analgesia Kappa- analgesia,sedation,dysphoria, diuresis Naloxone Pure opioid antagonist. Rapidly reverses opioid induced analgesia and repiratory depression. Short half life (lasts 1-2 hrs May require further doses (close monitoring) Precipitates withdrawal symptoms in opioid dependant patients. Morphine Gold standard Mu selective agonist Least lipid soluble,metabolised by liver, excreted kidneys. Can be given IM, IV, SC, oral, transmucosal, rectal epidural, intrathecal. Metabolic Toxicity Oral morphine loses 40% of potency to first pass effect. Potency of oral morphine to IV is about 3:1 IV provides rapid titration, shortest duration of action, complete systemic absorption. Morphine is metabolised by the liver to morphine-3-glucuronide (M3G) and morphine- 6-glucuronide (M6G) With impaired renal function M6G may accumulate and contribute to analgesia and prolonged sedation. With high dose morphine administration M3G may antagonise the action of morphine causing myoclonic jerks and hyperalgesia. 6

7 Morphine (cont) Dose required to control pain depends on many factors, and not related to any one parameter. There is no ceiling dose or normal range Right dose is that which controls the pain with fewest side effects. Breakthrough Doses Should be short acting and immediate release. Dose should be appoximately1/6 of daily dose. Eg MorphineSR 30mg bd Breakthrough Morphine IR 10mg IR every hour as needed. The rule of 3! If 3 or more breakthrough doses are needed in 24 hrs for 3 or more days the SR dose should be increased. Pethidine Mu selective agonist, weak affinity for NMDA receptor. Administer IV, IM,oral, rectal, transmucosal, epidural, intrathecal, (Not SC) Myocardial depression with larger doses Metabolised liver, excreted kidneys, contraindicated if taking MOIs. Pethidine Active metabolite norpethidine Accumulation of norpethidine associated with seizures and death. Toxicity will occur in approx 19% of cases where doses exceed 10mg/kg/day OR therapy exceeds 3 days. Impaired renal function increases half life of norpethidine. Naloxone does not reverse (and may aggravate) norpethidine toxicity. Agitation Irritability Nervousness Tremors Twitches Seizures Norpethidine Effects Fentanyl Highly lipid soluble Mu selective agonist Rapid onset, (peak IV 15 mins)short duration of action (IV 30-60mins) Inactive metabolites so good choice in renal impairment. IV, epidural, intrathecal, oral transmucosal ( lollipop ), transdermal (usually not in acute pain and caution in elderly) 7

8 DOSING Dosing schedule for opioids needs to be individualised. (large variation between individuals 5-7 fold.) Response determined in relation to both efficacy AND side effects. Opioid titration (small IV doses) best method for estimating optimal starting dose. In adult patient. In adults AGE rather than weight has been shown to be a better predictor of opioid requirement. Elderly patients require lower doses of opioids to achieve an equivalent analgesic effect and effect is often longer due to age related increase in terminal elimination half life of opioids. Dose Intervals Speed of onset of opioid will be influenced by route and lipid solubility. Time to max blood concentration depends primarily on administration route. Time to maximum effect then depends upon the rate at which the drug crosses to CNS and opioid receptors. 8

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1) Pain - subjective experience associated with detection of tissue damage ( nociception ) acute - serves as a warning chronic - nociception gone bad often accompanied by clinical depression fibromyalgia,

More information

Postoperative Pain Management. Nimmaanrat S, MD, FRCAT, MMed (Pain Mgt)

Postoperative Pain Management. Nimmaanrat S, MD, FRCAT, MMed (Pain Mgt) Postoperative Pain Management Nimmaanrat S, MD, FRCAT, MMed (Pain Mgt) Topics to be Covered Definition Neurobiology Classification Multimodal analgesia Preventive analgesia Step down approach Measurement

More information

Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008

Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008 Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008 PAIN MECHANISMS Somatic Nociceptive Visceral Inflammatory response sensitizes

More information

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4 Opioid MCQ OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4 OP02 [Mar96] Which factor does NOT predispose to bradycardia with

More information

BJF Acute Pain Team Formulary Group

BJF Acute Pain Team Formulary Group Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution

More information

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content Volume of Prescribing by Dentists 2011 ( a reminder) BASHD Therapeutics Analgesics and Pain Management Analgesics account for 1 in 80 dental prescriptions made A lot more analgesics will be suggested for

More information

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015 Analgesia for Patients with Substance Abuse Disorders Lisa Jennings CN November 2015 Definitions n Addiction: A pattern of drug use characterised by aberrant drug-taking behaviours & the compulsive use

More information

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I Mr.D.Raju,M.pharm, Lecturer Mechanisms of Pain and Nociception Nociception is the mechanism whereby noxious peripheral stimuli are transmitted to

More information

Ibuprofen. Ibuprofen and Paracetamol: prescribing overview. Ibuprofen indications CYCLO-OXYGENASE (COX I) CYCLO-OXEGENASE (COX II) INFLAMMATORY PAIN

Ibuprofen. Ibuprofen and Paracetamol: prescribing overview. Ibuprofen indications CYCLO-OXYGENASE (COX I) CYCLO-OXEGENASE (COX II) INFLAMMATORY PAIN Ibuprofen Ibuprofen and Paracetamol: prescribing overview Sarah Holloway Macmillan CNS in palliative care NSAID Non-selective COX inhibitor Oral bioavailability: 90% Onset of action: 20-30 mins (can take

More information

disease or in clients who consume alcohol on a regular basis. bilirubin

disease or in clients who consume alcohol on a regular basis. bilirubin NON-OPIOID Acetaminophen(Tylenol) Therapeutic class: Analgesic, antipyretic Aspirin (ASA, Acetylsalicylic Acid) Analgesic, NSAID, antipyretic Non-Opioid Analgesics COMMON USES WHAT I NEED TO KNOW AS A

More information

Acute Pain NETP: SEPTEMBER 2013 COHORT

Acute Pain NETP: SEPTEMBER 2013 COHORT Acute Pain NETP: SEPTEMBER 2013 COHORT Pain & Suffering an unpleasant sensory & emotional experience associated with actual or potential tissue damage, or described in terms of such damage International

More information

Pain Management Strategies Webinar/Teleconference

Pain Management Strategies Webinar/Teleconference Pain Management Strategies Webinar/Teleconference Barry K. Baines, MD April 16, 2009 Objectives Describe the principles of pain management. Identify considerations in the use of opioids. Describe the benefits

More information

Prescription Pain Management. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D

Prescription Pain Management. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D Prescription Pain Management University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D 2 Objectives Understand how to preform a pain assessment Know which medications

More information

Opioid Pharmacology. Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd. Consultant Anaesthetist Sheffield Teaching Hospitals

Opioid Pharmacology. Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd. Consultant Anaesthetist Sheffield Teaching Hospitals Opioid Pharmacology Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd Consultant Anaesthetist Sheffield Teaching Hospitals Introduction The available opioids and routes of administration - oral

More information

Cancer Pain. Suresh K Reddy, MD,FFARCS The University of Texas MD Anderson Cancer Center

Cancer Pain. Suresh K Reddy, MD,FFARCS The University of Texas MD Anderson Cancer Center Cancer Pain Suresh K Reddy, MD,FFARCS The University of Texas MD Anderson Cancer Center Prevalence of the Most Common Symptoms in Advanced Cancer (1000 Adults) Symptom % Symptom % Pain 82 Lack of Energy

More information

Palliative Prescribing - Pain

Palliative Prescribing - Pain Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing

More information

CHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient?

CHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient? CHAMP: Bedside Teaching TREATING PAIN Stacie Levine MD Teaching Trigger: An older adult patient is identified as having pain. Clinical Question: What is the approach to treating pain in the aging adult

More information

A. Correct! Nociceptors are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain.

A. Correct! Nociceptors are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain. Pharmacology - Problem Drill 19: Anti-Inflammatory and Analgesic Drugs No. 1 of 10 1. are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain. #01 (A) Nociceptors (B) Histamines

More information

Slide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists

Slide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists Slide 1 Opioid (Narcotic) Analgesics and Antagonists Chapter 6 1 Slide 2 Lesson 6.1 Opioid (Narcotic) Analgesics and Antagonists 1. Explain the classification, mechanism of action, and pharmacokinetics

More information

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid Definition All drugs, natural or synthetic, that bind to opiate receptors Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid agonists increase pain threshold

More information

6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages

6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages Nalbuphine: Analgesic with a Niche Mellar P Davis MD FCCP FAAHPM 1 Summary of Advantages Safe in renal failure- fecal excretion Analgesia equal to morphine with fewer side effects Reduced constipation

More information

Buprenorphine pharmacology

Buprenorphine pharmacology Buprenorphine pharmacology Victorian Opioid Management ECHO Department of Addiction Medicine St Vincent s Hospital Melbourne 2018 Page 1 Opioids full, partial, antagonist Full Agonists - bind completely

More information

Drugs Used In Management Of Pain. Dr. Aliah Alshanwani

Drugs Used In Management Of Pain. Dr. Aliah Alshanwani Drugs Used In Management Of Pain Dr. Aliah Alshanwani 1 Drugs Used In Management Of Pain A CASE OF OVERDOSE Sigmund Freud, the father of psychoanalysis His cancer of the jaw was causing him increasingly

More information

5 MUSCULOSKELETAL SYSTEM

5 MUSCULOSKELETAL SYSTEM 5 MUSCULOSKELETAL SYSTEM 5.01 NON-STEROIDAL ANTIILAMMATORY DRUGS (NSAIDS) *Acetylsalicylic Acid (Aspirin) Tab Soluble 300mg Diclofenac Sodium Tab 25mg, Supp 25mg, 50mg & 100mg (Voltaren) 300-900mg every

More information

Acute Pain Management in the Hospital Setting. Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX

Acute Pain Management in the Hospital Setting. Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX Acute Pain Management in the Hospital Setting Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX 2 What is Pain? An unpleasant sensory and emotional experience associated

More information

PAIN. Physiology of pain relating to pain management

PAIN. Physiology of pain relating to pain management PAIN Physiology of pain relating to pain management What is pain? An unpleasant sensory and emotional experience associated with actual or potential tissue damage. (Melzac and Wall) The generation of pain

More information

Clinical Guideline. Guidelines for the use of opioid analgesics in the management of acute pain in adults

Clinical Guideline. Guidelines for the use of opioid analgesics in the management of acute pain in adults Clinical Guideline Guidelines for the use of opioid analgesics in the management of acute pain in adults Document detail Document location West Kent and MTW Formulary Version 1.0 Effective from July 2017

More information

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage

More information

Pain management in palliative care. Dr. Stepanie Lippett and Sister Karen Davies-Linihan

Pain management in palliative care. Dr. Stepanie Lippett and Sister Karen Davies-Linihan Pain management in palliative care Dr. Stepanie Lippett and Sister Karen Davies-Linihan contents Concept of total pain Steps in pain management Recognising neuropathic pain WHO analgesic ladder Common

More information

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls Opioids, Overdose, and Fentanyls Outline: What are opioids? Why are we experiencing and opioid crisis? Potency, purity, and product How do opioids cause overdose and overdose deaths? What is naloxone and

More information

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK GUIDELINES AND AUDIT IMPLEMENTATION NETWORK General Palliative Care Guidelines The Management of Pain at the End Of Life November 2010 Aim To provide a user friendly, evidence based guide for the management

More information

E-Learning Module N: Pharmacological Review

E-Learning Module N: Pharmacological Review E-Learning Module N: Pharmacological Review This Module requires the learner to have read Chapter 13 of the Fundamentals Program Guide and the other required readings associated with the topic. Revised:

More information

PAIN PODCAST SHOW NOTES:

PAIN PODCAST SHOW NOTES: PAIN PODCAST SHOW NOTES: Dallas Holladay, DO Ultrasound Fellow Cook County Hospital Rush University Medical Center Jonathan D. Alterie, DO PGY-2, Emergency Medicine Midwestern University An overview of

More information

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA Pharmacogenetics of Codeine Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA 1 Codeine Overview Naturally occurring opium alkaloid Demethylated to morphine for analgesic effect

More information

OST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO

OST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO OST Pharmacology & Therapeutics Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO Disclaimer In the past two years I have received no payment for services from any agency other than government or academic.

More information

Methadone Maintenance

Methadone Maintenance Methadone Maintenance A Practical Guide to Pharmacotherapy Methadone/Buprenorphine 101 Workshop, April 1, 2017 Ron Joe, MD, DABAM Objectives I. Pharmacology Of Methadone II. Practical Application of Pharmacology

More information

PERIOPERATIVE PAIN MANAGEMENT: WHAT S UP WITH METHADONE?

PERIOPERATIVE PAIN MANAGEMENT: WHAT S UP WITH METHADONE? PERIOPERATIVE PAIN MANAGEMENT: WHAT S UP WITH METHADONE? Sandra Z Perkowski, VMD, PhD, DACVAA University of Pennsylvania, School of Veterinary Medicine, Philadelphia, PA Pre-emptive and multimodal use

More information

THE OPIUM POPPY OPIOID PHARMACOLOGY 2/18/16. PCTH 300/305 Andrew Horne, PhD MEDC 309. Papaver somniferum. Poppy Seeds Opiates

THE OPIUM POPPY OPIOID PHARMACOLOGY 2/18/16. PCTH 300/305 Andrew Horne, PhD MEDC 309. Papaver somniferum. Poppy Seeds Opiates OPIOID PHARMACOLOGY PCTH 300/305 Andrew Horne, PhD andrew.horne@ubc.ca MEDC 309 THE OPIUM POPPY Papaver somniferum Sleep-bringing poppy Poppy Seeds Opiates Opium Poppy Straw 1 OPIATES VS. OPIOIDS Opiates:

More information

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction Pain Management in Hepatic and Renal Dysfunction Review the pharmacologic basis for medications used in pain management Identify pain medications which hshould ldbe avoided in patients with hepatic dysfunction

More information

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117

More information

Review of Pain Management with Clinical and Regulatory Updates

Review of Pain Management with Clinical and Regulatory Updates Review of Pain Management with Clinical and Regulatory Updates Palliative Care Collaborative: 8 th Annual Regional Conference October 10, 2014 Michael Stellini, M.D.,M.S. Medical Director, Hospice and

More information

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes. Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical

More information

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti- Page 1 of 8 Analgesia The World Health Organisation (WHO, 1990) has devised a model to assist health care professionals in the management of cancer pain. The recommendations include managing pain, by the

More information

TRAPADOL INJECTION FOR I.V./I.M. USE ONLY

TRAPADOL INJECTION FOR I.V./I.M. USE ONLY TRAPADOL INJECTION FOR I.V./I.M. USE ONLY Composition : Each 2ml. contains : Tramadol Hydrochloride I.P. Water for injection I.P. 100mg. q.s. CLINICAL PHARMACOLOGY : Pharmacodynamics Tramadol is a centrally

More information

PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST

PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST TREATMENT IN ONCOLOGY Main treatment : surgery Neoadjuvant treatment : RT, CMT Adjuvant treatment : Tx micrometastatic disease -CMT,Targeted

More information

Pain Pathways. Dr Sameer Gupta Consultant in Anaesthesia and Pain Management, NGH

Pain Pathways. Dr Sameer Gupta Consultant in Anaesthesia and Pain Management, NGH Pain Pathways Dr Sameer Gupta Consultant in Anaesthesia and Pain Management, NGH Objective To give you a simplistic and basic concepts of pain pathways to help understand the complex issue of pain Pain

More information

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,

More information

Appendix D: Drug Tables

Appendix D: Drug Tables Appendix D: Drug Tables A. Short-acting, Orally Administered Opioids Table D-1: Use of Short-acting, Orally Administered Opioids in Adults [198] Additional Maximum APAP dose: 4000 mg/d (2000 mg/d in chronic

More information

Opioid Conversion Guidelines

Opioid Conversion Guidelines Opioid Conversion Guidelines March 2015 Gippsland Region Palliative Care Consortium Clinical Practice Group Title Keywords Ratified Opioid, Conversion, Drug, Therapy, Palliative, Guideline, Palliative,

More information

12/14/2018. Disclosures. Buprenorphine. Drug-Receptor Interactions. Affinity

12/14/2018. Disclosures. Buprenorphine. Drug-Receptor Interactions. Affinity ECHO Ontario Chronic Pain Bootcamp OPIOID CHALLENGE Buprenorphine/Naloxone: What and How? Friday, December 7, 2018 Disclosures Presenters: John Flannery & Andrew Smith Conflicts of Interest: None John

More information

! Somatic! Visceral! Neuropathic! Psychogenic. ! Analgesic! Relief without sedation! Works on peripheral pain receptors

! Somatic! Visceral! Neuropathic! Psychogenic. ! Analgesic! Relief without sedation! Works on peripheral pain receptors PAIN, PAIN, GO AWAY. TYPES OF PAIN! Somatic! Visceral! Neuropathic! Psychogenic Jill Autry, OD, RPh Eye Center of Texas, Houston drjillautry@tropicalce.com ANALGESIA! Mild! Aspirin! Paracetamol! Moderate!

More information

Pain Assessment & Management. For General Nursing Orientation

Pain Assessment & Management. For General Nursing Orientation Pain Assessment & Management For General Nursing Orientation April 2012 Overview Definition of pain Barriers to effective pain management Types of pain Objective pain assessment Approaches to management

More information

Advanced Pain Management LYRA SIHRA MD

Advanced Pain Management LYRA SIHRA MD Advanced Pain Management LYRA SIHRA MD Objectives Describe the importance of pain management Define the types of pain Discuss opioid pharmacology Identify barriers to pain management Discuss ethical responsibilities

More information

Po dilaudid versus iv dilaudid

Po dilaudid versus iv dilaudid Po dilaudid versus iv dilaudid Search IM/IV/SC 120 mg ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic an equianalgesic ratio for PO. Dilaudid official prescribing

More information

Karam Darwish. Dr. Munir. Munir Gharaibeh

Karam Darwish. Dr. Munir. Munir Gharaibeh 7 Karam Darwish Dr. Munir Munir Gharaibeh Opioid Analgesics Pain is an important symptom as it is usually the symptom that brings the patient to the hospital, and an Analgesic is a drug used to relieve

More information

Narcotic Analgesics. Jacqueline Morgan March 22, 2017

Narcotic Analgesics. Jacqueline Morgan March 22, 2017 Narcotic Analgesics Jacqueline Morgan March 22, 2017 Pain Unpleasant sensory and emotional experience with actual or potential tissue damage Universal, complex, subjective experience Number one reason

More information

Overview of Essentials of Pain Management. Updated 11/2016

Overview of Essentials of Pain Management. Updated 11/2016 0 Overview of Essentials of Pain Management Updated 11/2016 1 Overview of Essentials of Pain Management 1. Assess pain intensity on a 0 10 scale in which 0 = no pain at all and 10 = the worst pain imaginable.

More information

niap Terms and Definitions

niap Terms and Definitions Our topic today is about analgesics. niap General concept: pain brings patients to the Doctors at the same time. Fear from the pain can keep the patient from going to the Doctors at appropriate time. We

More information

BASICS OF OPIOID PRESCRIBING 10:30-11:45AM

BASICS OF OPIOID PRESCRIBING 10:30-11:45AM PROVIDING QUALITY CARE TO PAIN PATIENTS IN IOWA BASICS OF OPIOID PRESCRIBING 10:30-11:45AM ACPE UAN: 107-000-14-013-L01-P Activity Type: Application-Based 0.125 CEU/1.25hr Learning Objectives for Pharmacists:

More information

BACKGROUND Measuring renal function :

BACKGROUND Measuring renal function : A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

More information

Name: Class: "Pharmacology NSAIDS (1) Lecture

Name: Class: Pharmacology NSAIDS (1) Lecture I Name: Class: "Pharmacology NSAIDS (1) Lecture د. احمد الزهيري Inflammation is triggered by the release of chemical mediators from injured tissues and migrating cells. The specific mediators vary with

More information

OAT Transitions - focus on microdosing. Mark McLean MD MSc FRCPC CISAM DABAM

OAT Transitions - focus on microdosing. Mark McLean MD MSc FRCPC CISAM DABAM OAT Transitions - focus on microdosing Mark McLean MD MSc FRCPC CISAM DABAM Disclosures No pharmaceutical industry or other financial conflicts of interest Study Physician for research funded by Canadian

More information

Non Malignant Pain: Symptom Management

Non Malignant Pain: Symptom Management Non Malignant Pain: Symptom Management Renal Care Symposium July 2018 Anica Vasic Pain Management Unit St George Hospital Definitions Prevalence Assessment Treatment Medications Newer agents: tapentadol,

More information

PARACOD Tablets (Paracetamol + Codeine phosphate)

PARACOD Tablets (Paracetamol + Codeine phosphate) Published on: 22 Sep 2014 PARACOD Tablets (Paracetamol + Codeine phosphate) Composition PARACOD Tablets Each effervescent tablet contains: Paracetamol IP...650 mg Codeine Phosphate IP... 30 mg Dosage Form/s

More information

Opioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue

Opioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue Opioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue Scope Pharmacology of Opioids Equivalence Dependence and Withdrawal Methadone Maintenance (OST) 3 Opioid

More information

Enhanced Community Palliative Support Services. Lynne Ghasemi St Luke s Hospice

Enhanced Community Palliative Support Services. Lynne Ghasemi St Luke s Hospice Enhanced Community Palliative Support Services Lynne Ghasemi St Luke s Hospice Learning Outcomes Define the different types of pain Describe the process of pain assessment Discuss pharmacological management

More information

Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center

Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center Pharmacologic Management of Pain Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center Objectives Identify types of

More information

Analgesia for Small Animals Pharmacology & Clinical Practice. Jill Maddison The Royal Veterinary College Hawkshead Lane, North Mymms, AL9 7TA, UK

Analgesia for Small Animals Pharmacology & Clinical Practice. Jill Maddison The Royal Veterinary College Hawkshead Lane, North Mymms, AL9 7TA, UK Analgesia for Small Animals Pharmacology & Clinical Practice Jill Maddison The Royal Veterinary College Hawkshead Lane, North Mymms, AL9 7TA, UK Colin Dunlop Advanced Anaesthesia Specialists Unit 13, 46-48

More information

Berkshire West Area Prescribing Committee Guidance

Berkshire West Area Prescribing Committee Guidance Guideline Name Berkshire West Area Prescribing Committee Guidance Date of Issue: September 2015 Review Date: September 2017 Date taken to APC: 2 nd September 2015 Date Ratified by GP MOC: Guidelines for

More information

Gateshead Pain Guidelines for Chronic Conditions

Gateshead Pain Guidelines for Chronic Conditions Gateshead Pain Guidelines for Chronic Conditions Effective Date: 13.2.2013 Review Date: 13.2.2015 Gateshead Pain Guidelines: Contents PAIN GUIDELINES Chronic Non-Malignant Pain 5 Musculoskeletal Pain 6

More information

Acute pain management in opioid tolerant patients. Muhammad Laklouk

Acute pain management in opioid tolerant patients. Muhammad Laklouk Acute pain management in opioid tolerant patients Muhammad Laklouk General principles An adequate review and assessment Provision of effective analgesia (including attenuation of tolerance and hyperalgesia)

More information

Opioid rotation or switching may be considered if a patient obtains pain relief with one opioid and is suffering severe adverse effects.

Opioid rotation or switching may be considered if a patient obtains pain relief with one opioid and is suffering severe adverse effects. Dose equivalence and switching between opioids Key Messages Switching from one opioid to another should only be recommended or supervised by a healthcare practitioner with adequate competence and sufficient

More information

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Substitution Therapy for Opioid Use Disorder The Role of Suboxone Substitution Therapy for Opioid Use Disorder The Role of Suboxone Methadone/Buprenorphine 101 Workshop, December 10, 2016 Leslie Lappalainen, MD, CCFP, dip ABAM Prepared by Mandy Manak, MD, ABAM, CCSAM

More information

Opioid Pearls and Acute Pain Management

Opioid Pearls and Acute Pain Management Opioid Pearls and Acute Pain Management Jeanie Youngwerth, MD University of Colorado Denver Assistant Professor of Medicine, Hospitalist Associate Director, Colorado Palliative Medicine Fellowship Program

More information

SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults

SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults BACKGROUND The justification for developing these guidelines lies

More information

Pain Management for Adult sickle cell disease patients: Information for patients, relatives and carers

Pain Management for Adult sickle cell disease patients: Information for patients, relatives and carers Pain Management for Adult sickle cell disease patients: Information for patients, relatives and carers Why you should read this leaflet This leaflet will give you the information necessary to manage your

More information

Prescribing and Administration of Analgesia within Maternity

Prescribing and Administration of Analgesia within Maternity Prescribing and Administration of Analgesia within Maternity CONTENTS Introduction and Who The Guideline Applies To... 2 UHL Paracetamol Prescribing Guideline... 2 Oral dosing... 2 Intravenous dosing...

More information

Post-caesarean analgesia. Genevieve Goulding Royal Brisbane & Women's Hospital 1

Post-caesarean analgesia. Genevieve Goulding Royal Brisbane & Women's Hospital 1 Post-caesarean analgesia Genevieve Goulding Royal Brisbane & Women's Hospital 1 Contemporary challenges & barriers to providing optimal post-caesarean analgesia Genevieve Goulding Royal Brisbane & Women's

More information

What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls?

What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls? What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls? What is an opioid? What do opioids do?: The term opioid can be

More information

LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE

LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE DR. SHILPA ADARKAR ASSOCIATE PROFESSOR DEPARTMENT OF PSYCHIATRY & DRUG DEADDICTION CENTRE OF EXCELLENCE SETH GSMC & KEMH LONG TERM OPTIONS FULL AGONIST PARTIAL

More information

Oxymorphone (Opana ) is indicated for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate.

Oxymorphone (Opana ) is indicated for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate. Page 1 of 7 Policies Repository Policy Title Policy Number Schedule II Prior Authorization FS.CLIN.16 Application of Pharmacy Policy is determined by benefits and contracts. Benefits may vary based on

More information

Acute Pain Management

Acute Pain Management Acute Pain Management Dr Zamil Karim MBBS, FANZCA,FFPMANZCA, FIPP The journey to Acute pain management begins in the perioperative period. The evaluation and assessment occurs in the perioperative period

More information

Slide 1. Slide 2. Slide 3. Drug Action and Handling. Lesson 2.1. Lesson 2.1. Drug Action and Handling. Drug Action and Handling.

Slide 1. Slide 2. Slide 3. Drug Action and Handling. Lesson 2.1. Lesson 2.1. Drug Action and Handling. Drug Action and Handling. Slide 1 Drug Action and Handling Chapter 2 1 Slide 2 Lesson 2.1 Drug Action and Handling 1. Differentiate dose, potency, and efficacy in the context of the actions of drugs. 2. Explain the pharmacologic

More information

CHAPTER 4 PAIN AND ITS MANAGEMENT

CHAPTER 4 PAIN AND ITS MANAGEMENT CHAPTER 4 PAIN AND ITS MANAGEMENT Pain Definition: An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Types of Pain

More information

B. Long-acting/Extended-release Opioids

B. Long-acting/Extended-release Opioids 4 Opioid tolerance is assumed in patients already taking fentanyl 25 mcg/hr OR daily doses of the following oral agents for 1 week: 60 mg oral morphine, 30 mg oxycodone, 8 mg hydromorphone, 25 mg of oxymorphone

More information

POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS

POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS November 9, 2018 Aimee LaMere, CNP Molly McNaughton, CNP Leslie Weide, MSW, LICSW, ACM Disclosures: Conflict of interest statement: We certify that,

More information

IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE?

IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE? NON-OPIOID TREATMENT OPTIONS FOR CHRONIC PAIN Alison Knutson, PharmD, BCACP Medication Management Pharmacist Park Nicollet Creekside Clinic Dr. Knutson indicated no potential conflict of interest to this

More information

Understanding pain in 5 minutes

Understanding pain in 5 minutes Pain Management- PallCare Definition of Pain Pain is what the patient says hurts. Dr Simon Allan Director of Palliative Care Arohanui Hospice An unpleasant sensory and emotional experience associated with

More information

1/21/14. Cancer Related Pain: Case-Based Pharmacology. Conflicts of Interest. Learning Objective

1/21/14. Cancer Related Pain: Case-Based Pharmacology. Conflicts of Interest. Learning Objective Cancer Related Pain: Case-Based Pharmacology Jeannine M. Brant, PhD, APRN, AOCN Oncology Clinical Nurse Specialist Nurse Scientist Billings Clinic Conflicts of Interest Jeannine Brant has served on the

More information

PRODUCT INFORMATION Panadeine EXTRA

PRODUCT INFORMATION Panadeine EXTRA PRODUCT INFORMATION Panadeine EXTRA COMPOSITION Each caplet brand of capsule-shaped tablet contains: Paracetamol 500 mg Codeine phosphate 15 mg and Maize Starch Purified Talc Pregelatinised Maize Starch

More information

Pain. November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine

Pain. November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine Pain November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine Objectives To be able to define pain To be able to evaluate pain To be able to classify types of pain To learn appropriate

More information

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine Natural derivatives of opium poppy - Opium - Morphine - Codeine Opioid Agonists Semi synthetics: Derived from chemicals in opium -Diacetylmorphine Heroin - Hydromorphone Synthetics - Oxycodone Propoxyphene

More information

OPIOID- INDUCED NEUROTOXICITY*

OPIOID- INDUCED NEUROTOXICITY* OPIOID- INDUCED NEUROTOXICITY* Sriram Yennu MD, MS, FAAHPM Palliative Care, Rehabilitation and Integrative Medicine U.T. M.D. Anderson Cancer Center *Slide Deck courtesy Dept PRIM MDACC PATIENT #1: MRS

More information

Fentanyls and Naloxone. Opioids, Overdose, and Naloxone

Fentanyls and Naloxone. Opioids, Overdose, and Naloxone Opioids, Overdose, and Naloxone Presenter Disclosure Presenter s Name: Michael Beazely I have no current or past relationships with commercial entities Speaking Fees for current program: I have received

More information

Screening - inclusion criteria

Screening - inclusion criteria PAIN OUT Community research EU ROP EAN COMMISSION A Date of data collection: B Time of data collection: C Ward where data is collected: 2 0 1 Y M M D D H H M M D Research assistant Code: Room number: Screening

More information

Balanced Analgesia With NSAIDS and Coxibs. Raymond S. Sinatra MD, Ph.D

Balanced Analgesia With NSAIDS and Coxibs. Raymond S. Sinatra MD, Ph.D Balanced Analgesia With NSAIDS and Coxibs Raymond S. Sinatra MD, Ph.D Prostaglandins and Pain The primary noxious mediator released from damaged tissue is prostaglandin (PG) PG is responsible for nociceptor

More information

Q&A: Opioid Prescribing for Chronic Non-Malignant Pain

Q&A: Opioid Prescribing for Chronic Non-Malignant Pain NHS Hastings and Rother Clinical Commissioning Group Chair Dr David Warden Chief Officer Amanda Philpott NHS Eastbourne, Hailsham and Seaford Clinical Commissioning Group Chair Dr Martin Writer Chief Officer

More information

Analgesics: Management of Pain In the Elderly Handout Package

Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain in the Elderly Each patient or resident and their pain problem is unique. A complete assessment should be performed

More information

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP).

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP). Surrey (East Surrey CCG, Guildford & Waverley CCG, North West Surrey CCG, Surrey Downs CCG & Surrey Heath CCG) North East Hampshire & Farnham CCG and Crawley, Horsham & Mid-Sussex CCG Guidelines for the

More information

Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly

Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly Mary Lynn McPherson, PharmD, MDE, MA, BCPS, CPE Professor and Executive Director, Advanced Post-Graduate

More information